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ALBU, Albumin; AMPK, 5' AMP-activated protein kinase; ANKR2, ankyrin repeat domain 37 
protein; CAH3, carbonic anhydrase 3; CRYAB, alpha B-crystallin; D2O, Deuterium oxide; 38 
DPP, Dynamic Proteome Profiling; FAT/CD36, fatty acid translocase; FFA, Free fatty acids;  39 
FFM, Fat free mass; FLNC, Filamin-C; GPR56, G protein-coupled receptor 56; HFLC, High 40 
Fat Low Carbohydrate; HSPB1, heat shock protein; IL-6, Interleukin-6; IQR, inter-quartile 41 
range; MAFbx, Muscle Atrophy F-box; MyHC, myosin heavy chain; MPE, molar per-cent 42 
enrichment; MuRF1, Muscle-specific RING Finger protein-1; mTOR, mechanistic target of 43 
rapamycin; OGTT, Oral Glucose Tolerance Test; ODPB, Pyruvate dehydrogenase E1 44 
component subunit beta; PAI-1, Plasminogen activator inhibitor type 1; PDK4, Pyruvate 45 
dehydrogenase lipoamide kinase isozyme 4; PEBP1, Phosphatidylethanolamine-binding 46 
protein 1; PGC-1α, Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 47 
PRDX6, Peroxiredoxin-6; PROF1, Profilin-1; REX, Resistance Exercise; RKIP, RAF kinase 48 
inhibitor protein; TNNC2, Troponin C; TNF-α, Tissue Necrosis Factor-α; TRFE, Transferrin 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
 3 
Abstract 69 
It is generally accepted that muscle adaptation to resistance exercise training is underpinned 70 
by contraction-induced increased rates of protein synthesis and dietary protein availability. 71 
Utilising Dynamic Proteome Profiling (DPP), we investigated the contributions of both 72 
synthesis and breakdown to changes in abundance on a protein-by-protein basis in human 73 
skeletal muscle. Age-matched, overweight males consumed nine days of a high-fat, low-74 
carbohydrate (HFLC) diet during which time they either undertook three sessions of 75 
resistance exercise (REX) or performed no exercise. Precursor enrichment and the rate of 76 
incorporation of deuterium oxide (D2O) into newly synthesised muscle proteins were 77 
determined by mass spectrometry. Ninety proteins were included in the DPP with 28 proteins 78 
exhibiting significant responses to REX. The most common pattern of response was an 79 
increase in turnover, followed by an increase in abundance with no detectable increase in 80 
protein synthesis. We provide novel evidence demonstrating that the contribution of synthesis 81 
and breakdown to changes in protein abundance induced by REX differ on a protein-by-82 
protein basis. We also highlight the importance of the degradation of individual muscle 83 
proteins following exercise in human skeletal muscle. 84 
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Skeletal muscle displays remarkable plasticity with the capacity to alter its phenotype in 90 
response to contractile activity and nutrient availability (1, 2). Resistance exercise (REX) 91 
increases muscle size and contractile strength and is an important intervention to prevent the 92 
muscle loss associated with disuse, ageing or disease-related cachexia (2). Exercise-induced 93 
gains in muscle mass are commonly attributed to a greater protein synthetic response. Indeed, 94 
a single bout of REX increases muscle protein fractional synthetic rate ~20% above basal 95 
levels (3-5), a response further augmented with amino acid ingestion (6-8).  96 
In humans the synthesis and degradation of muscle proteins in vivo has been extensively 97 
investigated via metabolic labelling experiments using sterile intra-venous infusions of stable 98 
isotopes such as [2H5]-phenylalanine (5, 9). However, the acute elevations in muscle protein 99 
synthesis estimated by these techniques do not always correlate with muscle hypertrophy 100 
responses induced by chronic REX (10, 11). Additionally, the acute nature of amino acid 101 
tracer methods (i.e. time course of < 12 hours) means changes in protein turnover during 102 
fasted (sleeping) periods and over several days are not captured. Metabolic labelling with 103 
deuterium oxide (D2O) offers an elegant solution to investigate the chronic effects of 104 
exercise-nutrient interactions on rates of muscle protein synthesis and degradation because it 105 
can be administered via drinking water to free-living humans over prolonged periods (weeks 106 
to months) allowing measurement under ‘real world’ conditions of habitual diet and activity 107 
patterns (12). Using these techniques, Brook and colleagues recently reported an 18% 108 
increase in the synthesis rate of mixed myofibrillar proteins during the first 3 wk of a REX 109 
intervention that accounted for most of the observed increase in muscle mass (13). However, 110 
that study did not measure individual protein responses to exercise, so the relationship 111 
between an average increase in synthesis across mixed myofibrillar proteins and selective 112 
changes in myofibrillar protein abundance was not clear. A greater understanding of protein 113 
specific responses, including rates of synthesis, degradation and abundance, is important 114 
given that suppression of the rate of renewal of some proteins can result in aggregation, gain-115 
of-function toxicity and a loss of proteome quality (proteostasis), a hallmark of ageing (14). 116 
In a comprehensive study of muscle protein responses to exercise, we combine state-of-the-117 
art measurements of protein synthesis rates with well-established label-free profiling methods 118 
(15-17) that are considered the “gold-standard” for measuring relative changes in protein 119 
abundance in humans. For the first time, we report the anabolic effects of REX on the 120 
synthesis, breakdown and abundance of individual muscle proteins in human skeletal muscle. 121 
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Specifically, we investigated whether a short-term high-fat, low carbohydrate (HFLC) diet 122 
impairs rates of muscle protein synthesis, degradation and abundance, as such diets are often 123 
promoted for rapid weight loss. However, a common shortcoming of HFLC diets is that they 124 
fail to confer protection against the debilitating loss of skeletal muscle mass (18) and 125 
therefore provide a suitable model to measure synthesis and degradation rates of individual 126 
muscle proteins.   127 
Materials and Methods 128 
Subjects Sixteen sedentary, untrained, otherwise healthy male subjects were recruited for this 129 
study (Table 1). Participants were provided with oral and written information about the 130 
purpose, nature and potential risks involved with the study, and written informed consent was 131 
obtained prior to participation. The study was approved by the Australian Catholic University 132 
Human Research Ethics Committee and conformed with the policy statement regarding the 133 
use of human subjects in the latest revision of the Declaration of Helsinki. The trial was 134 
registered with the Australian New Zealand Clinical Trials Registry (ACTRN 369316). The 135 
study employed a between-subjects design where subjects were pair-matched for fat free 136 
mass and strength and allocated to either an exercise (n = 8, REX) or non-exercise (n = 8, 137 
HFLC) group for the experimental trial. Previous studies measuring individual muscle 138 
proteome responses in humans have been performed in only 3-6 participants (19, 20). 139 
Moreover, we did not allow any missing values in our proteomic analyses (proteins that could 140 
not be measured in all 16 participants at all time points were excluded).  141 
 142 
Preliminary Testing and Control Diet: Preliminary Testing VO2peak and Maximum Strength 143 
were determined two-weeks prior to the commencement of experimental trials (described 144 
subsequently). VO2peak was determined during an incremental test to volitional fatigue on a 145 
Lode cycle ergometer (Groningen, The Netherlands) (21). Quadriceps strength was 146 
determined during a series of single repetitions on a pin-loaded leg extension (Cybex, 147 
Massachusetts, USA) and leg press (Synergy Leg Press, Queensland, Australia) machine until 148 
the maximum load lifted was established (1 RM) (6). Body composition (fat mass and fat free 149 
mass (FFM)) was measured using whole-body dual-energy x-ray absorptiometry (DXA) 150 
scans (GE Lunar iDXA Pro, enCORE software Version 16) under standardized conditions. 151 
VO2peak, strength and body composition were determined two weeks prior to experimental 152 
trials during which time subjects maintained their habitual diet and physical activity patterns. 153 
Following preliminary testing, participants were instructed to refrain from exercise training, 154 
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vigorous physical activity, alcohol and caffeine consumption for the 72 h before commencing 155 
the 9-day high fat diet and exercise experimental period (described subsequently). During this 156 
time, participants were also provided with standardized prepacked meals for breakfast, lunch, 157 
dinner and snacks that provided an energy availability of 45 kcal·kg fat-free mass (FFM) 158 
−1·day−1 consisting of 6.1 g carbohydrate/kg FFM (55% caloric intake), 1.7 g protein/ kg FFM 159 
(15%) and 1.5 g fat/ kg FFM (30%) (Figure 1). 160 
 161 
High Fat Low Carbohydrate (HFLC) Diet. On the next morning following the diet and 162 
exercise control period, participants reported to the laboratory after a ~10-h overnight fast. 163 
After resting in the supine position for ~15 min, a catheter was inserted into the antecubital 164 
vein of one arm and a baseline blood sample (~5 mL) was taken. Under local anaesthesia (2–165 
3 mL of 1% Xylocaine) a resting biopsy (Day 1) was obtained from the vastus lateralis using 166 
a 5-mm Bergstrom needle modified with suction. An oral glucose tolerance test (OGTT) was 167 
then conducted using a 75 g 300 mL glucose solution with blood samples obtained every 30 168 
min up to 2 h. Participants were then provided their HFLC diet to be consumed as their only 169 
caloric intake for the next 9 days consisting of 0.8g carbohydrate kg/ FFM (8% total caloric 170 
intake), 1.7 g protein/ kg FFM (15%) and 3.9 g fat/ kg FFM (77%) (Figure 1). This diet 171 
followed guidelines previously reported (22). Total energy intake was based on an energy 172 
availability of 45 kcal·kg FFM−1·day−1 to ensure participants were in energy balance, and 173 
meal plans were created using Foodworks 7.0 ® Xyris Software (Melbourne, Australia). 174 
Menu construction and the preparation of meals and snacks were undertaken by food service 175 
dietitians and sports dietitians (Dineamic, Camberwell, Victoria). Meal plans were 176 
individually developed for each participant to integrate individual food preferences and BM. 177 
All meals and snacks were supplied to subjects. Participants were required to keep a food 178 
checklist to note their compliance to the dietary instructions and their intake of any additional 179 
food or drinks. Every 2 days, participants met with a dietician to receive new food parcels 180 
and check their adherence to the previous days' diet. Additional muscle biopsies were 181 
obtained on Day 3 and 6 of the HFLC diet. Each muscle biopsy was taken under fasted 182 
conditions from a separate site 2-3 cm distal from the same leg and moving in a proximal 183 
direction with successive biopsies with all samples stored at -80°C until subsequent analysis. 184 
Blood samples were obtained every morning in EDTA tubes via venepuncture from the 185 
antecubital vein on alternate arms. All blood samples were immediately centrifuged at 1,000 186 
g at 4°C for 15 min, with aliquots of plasma frozen in liquid N2 and stored at −80°C. The 187 
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morning following the HFLC diet, an additional muscle biopsy was obtained and participants 188 
then underwent another OGTT as previously described. 189 
 190 
Deuterium Labelling Protocol Deuterium labelling of newly synthesized proteins was 191 
achieved by oral consumption of D2O (Sigma Aldrich, Castle Hill, Australia) based on 192 
previous work (19). To achieve an appropriate target enrichment of 1–2%, participant’s 193 
consumed 50 ml of 99.8 atom % D2O four times a day for a total of 200 mL per day for all 194 
days of the HFLC intervention commencing after the first muscle biopsy on Day 1. All 50 195 
mL doses were provided in individually sealed bottles purchased from Sigma Aldrich and 196 
participants were instructed to consume each dose at least 3-4 h apart. 197 
 198 
Resistance Exercise Participants in the REX group performed a resistance exercise session on 199 
Day 1, 4 and 7 of the HFLC diet. The resistance exercise session consisted of 4 X 8-10 200 
repetitions of leg press at 80% 1-RM, 4 X 8-10 repetitions of leg extension at 80% 1-RM, and 201 
4 sets of dumbbell squats. Each set was separated by a 3-min recovery period during which 202 
time participants rested. 203 
 204 
Gas chromatography-mass spectrometry Body water enrichment of D2O was measured in 205 
plasma samples against external standards constructed by adding D2O to phosphate buffered 206 
saline over the range from 0.0 to 3.0 % in 0.5 % increments. The D2O enrichment of aqueous 207 
solutions was determined after exchange with acetone (23). Samples were centrifuged at 208 
12,000 g, 4 ºC for 10 min and 20 μL of plasma supernatant or standard was reacted overnight 209 
at room temperature with 2 μL of 10 N NaOH and 4 μL of 5 % (v/v) acetone in acetonitrile. 210 
Acetone was then extracted in to 500 μL chloroform and water was captured in 0.5 g Na2SO4 211 
prior to transferring a 200 μL aliquot of chloroform to an auto-sampler vial. Samples and 212 
standards were analysed in triplicate using an Agilent 5973N mass selective detector coupled 213 
to an Agilent 6890 gas chromatography system. A CD624-GC column (30 m x 0.25 mm x 214 
1.40 μ m) was used in all analyses. Samples (1 μL) were injected using an Agilent 7683 auto 215 
sampler. The temperature program began at 50 °C and increased by 30 °C/min to 150 °C, and 216 
was held for 1 min. The split ratio was 50:1 with a helium flow of 1.5 mL/min. Acetone 217 
eluted at approximately 3.0 min. The mass spectrometer was operated in the electron impact 218 
mode (70 eV) and selective ion monitoring of m/z 58 and 59 was performed using a dwell 219 
time of 10 ms/ion. 220 
 221 
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Muscle processing Muscle samples (~60 mg) were pulverised in liquid nitrogen then 222 
homogenised on ice in 10 volumes of 1% Triton X-100, 50 mM Tris pH 7.4 containing 223 
Complete™ protease inhibitor (Roche Diagnostics, Lewes, UK) using a PolyTron 224 
homogeniser. Samples were incubated on ice for 15 min then centrifuged at 1,000 g, 4°C for 225 
5 min. Supernatants containing soluble/ sarcoplasmic proteins were decanted and stored on 226 
ice while the myofibrillar pellet was resuspended in 0.5 ml of homogenisation buffer and then 227 
centrifuged at 1,000 g, 4°C for 5 min. The washed myofibrillar pellet was then solubilised in 228 
0.5 ml of 7 M urea, 2 M thiourea, 4 % CHAPS, 30 mM Tris pH 8.5 and cleared by 229 
centrifugation at 12,000 g, 4°C for 45 min. The protein concentrations of both the 230 
myofibrillar fraction and sarcoplasmic fraction were measured using the Bradford assay 231 
(Sigma, Poole, Dorset, UK). Aliquots containing 100 μg protein were precipitated in 5 232 
volumes of acetone for 1 hour at −20°C. Pellets were resuspended in 0.1% (w/v) Rapigest SF 233 
(Waters; Milford, MA, USA) in 50 mM ammonium bicarbonate and incubated at 80°C for 15 234 
min. Samples were washed with 0.1% (w/v) Rapigest SF (Waters; Milford, MA, USA) in 50 235 
mM ammonium bicarbonate using spin columns with 5 kDa molecular weight filters and 236 
adjusted to a final volume of 100 μL. DTT was added (final concentration 1 mM) and 237 
incubated at 60°C for 30 min followed by incubation (30 min) while being protected from 238 
light in the presence of 5 mM iodoacetamide at 4°C. Sequencing grade trypsin (Promega; 239 
Madison, WI, USA) was added at a protein ratio of 1:50 and digestion allowed to proceed at 240 
37°C overnight. Digestion was terminated by the addition of 2 μL concentrated TFA and 241 
peptide solutions were cleared by centrifugation at 15,000 g for 15 min. 242 
 243 
Liquid chromatography-mass spectrometry Label-free liquid chromatography-mass 244 
spectrometry (LC-MS) analysis was performed using nanoscale reversed-phase ultra-245 
performance liquid chromatography (nanoACQUITY, Waters, Milford, MA) and online 246 
electrospray ionisation (ESI) quadrupole - time of flight mass spectrometry (Q-TOF Premier, 247 
Waters, Manchester, UK). Samples (400 ng tryptic peptides) were loaded in aqueous 0.1% 248 
(v/v) formic acid via a Symmetry C18 5 μm, 2 cm x 180 μm trap column (Waters, Milford, 249 
MA). Separation was conducted at 35 ºC through a BEH C18 1.7 μm, 25 cm x 75 μm 250 
analytical reverse phase column (Waters, Milford, MA). Peptides were eluted using a 251 
gradient rising to 37 % acetonitrile 0.1% (v/v) formic acid over 90 min at a flow rate of 300 252 
nL/min. For all measurements, the mass spectrometer was operated in a data-dependent 253 
positive ESI mode at a resolution of >10,000 FWHM. Prior to analysis, the time of flight 254 
analyser was calibrated using fragment ions of [Glu-1]-fibrinopeptide B from m/z 50 to 1990. 255 
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Mass spectra for LC-MS profiling were recorded between 350 m/z and 1600 m/z using MS 256 
survey scans of 0.45 s duration with an inter-scan delay of 0.05 s. In addition, equivalent 257 
data-dependent tandem mass spectrometry (MS/MS) spectra were collected from each D0 258 
(control) sample. MS/MS spectra of collision-induced dissociation fragment ions were 259 
recorded for the 5 most abundant precursor’s ions of charge 2+ or 3+ detected in the survey 260 
scan. Precursor fragmentation was achieved by collision induced dissociation (CID) at an 261 
elevated (20-40 eV) collision energy over a duration of 0.15 s per parent ion with an inter-262 
scan delay of 0.05 s over 50-2000 m/z. Acquisition was switched from MS to MS/MS mode 263 
when the base peak intensity (BPI) exceeded a threshold of 750 counts per second, and 264 
returned to the MS mode when the TIC in the MS/MS channel exceeded 50000 counts/s or 265 
when 1.0 s (5 scans) were acquired. To avoid repeated selection of peptides for MS/MS the 266 
program used a 30 s dynamic exclusion window. 267 
 268 
Progenesis protein profiling Progenesis QI for proteomics (QI⋅P; Nonlinear Dynamics, 269 
Newcastle, UK) was used to perform label-free quantitation consistent with our previous 270 
work (15-17). Prominent ion features (>600 per chromatogram) were used as vectors to warp 271 
each dataset to a common reference chromatogram. An analysis window of 15 min - 105 min 272 
and 350 m/z - 1500 m/z was selected, which encompassed a total of 7,018 features with 273 
charge states of +2 or +3. Log transformed MS data were normalised by inter-sample 274 
abundance ratio and differences in relative protein abundance were investigated using non-275 
conflicting peptides only. MS/MS spectra (48, 601 queries) were exported in Mascot generic 276 
format and searched against the Swiss-Prot database (2016.7) restricted to ‘Homo Sapiens’ 277 
(20,272 sequences) using a locally implemented Mascot (www.matrixscience.com) server 278 
(version 2.2.03). The enzyme specificity was trypsin allowing 1 missed cleavage, 279 
carbamidomethyl modification of cysteine (fixed), deamination of asparagine and glutamine 280 
(variable), oxidation of methionine (variable) and an m/z error of ± 0.3 Da. The Mascot 281 
output (xml format), restricted to non-homologous protein identifications was recombined 282 
with MS profile data and peptides modified by deamination or oxidation were removed prior 283 
to quantitative analysis.  284 
 285 
Measurement of protein synthesis rates Protein synthesis rates were calculated using mass 286 
isotopomer distribution analysis consistent with previous work (19). Mass isotopomer 287 
abundance data were extracted from MS only spectra using Progenesis Quantitative 288 
Informatics (QI; Nonlinear Dynamics, Newcastle, UK). Peak picking was performed on ion 289 
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features with +1, +2 or +3 charge states within an analysis window of 15 min - 105 min and 290 
350 m/z - 1500 m/z. The abundance of M0-M3 mass isotopomers were collected over the 291 
entire chromatographic peak for each non-conflicting peptide that was used for label-free 292 
quantitation in the aforementioned Progenesis QI⋅P analysis. Mass isotopomer information 293 
was exported from Progenesis QI and processed in R version 3.3.1 (24) according to 294 
published methods (19). Briefly, the incorporation of deuterium in to newly synthesised 295 
protein causes a decrease in the abundance (Figure 1) of the monoisotopic (M0) peak relative 296 
to the abundances of the M1, M2 and M3 isotopomers that contain 1, 2 or 3 ‘heavy’ isotopes 297 
(e.g. 13C, D2O, 15N, etc.). Over the duration of the experiment, changes in mass isotopomer 298 
distribution follow a non-linear bi-exponential pattern due to the rise-to-plateau kinetics in 299 
precursor enrichment (body water D2O enrichment measured in plasma samples by GC-MS) 300 
and the rise-to-plateau kinetics of D2O-labelled amino acids in to newly synthesised protein. 301 
Therefore, a machine learning approach was taken employing the Nelder-Mead method to 302 
optimise for the rate of change in the relative abundance of the monoisotopic (M0) peak. The 303 
rate of change in mass isotopomer distribution is also a function of the number (n) of 304 
exchangeable H sites and this was accounted for by referencing each peptide sequence 305 
against standard tables reporting the relative enrichment of amino acids by tritium in mice 306 
(25) or deuterium in humans (26) to give the synthesis rate (k) for each peptide. 307 
Supplementary tables S1 and S2 report the raw mass spectrometry data for each peptide 308 
analysed in the myofibrillar and sarcoplasmic fractions, respectively. Peptide synthesis rates 309 
across each protein were averaged to give a synthesis rate for that protein in each individual 310 
participant.   311 
 312 
Estimation of protein breakdown rates. The rate of change in the abundance of a protein is 313 
dependent on the difference between its rate of synthesis ks and rate of breakdown kd.  We 314 
assumed each of these was constant and used first-order kinetics following the standard 315 
formula: 316 
𝐴 = 𝐴0𝑒(𝑘𝑠−𝑘𝑑)(𝑡−𝑡0) 
where A is the abundance at time t and A0 is the abundance at time t0. Using protein 317 
abundance data at times t and t0 the net rate of change in abundance can be calculated by 318 
rearranging the above to give: 319 
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𝑘𝑠 − 𝑘𝑑 =
1
𝑡 − 𝑡0
ln
𝐴
𝐴0
 
Converting differences in abundance between D0 and D9 to rates of change in abundance 320 
enables the rate of breakdown of each protein to be calculated as the difference between its 321 
rate of synthesis and its rate of change in abundance. Supplementary table S3 summarises the 322 
mean (n=8 in each group) abundance, synthesis and degradation data for each protein 323 
investigated in the sarcoplasmic and myofibrillar fractions. 324 
 325 
Plasma Analysis Plasma glucose concentration was measured via an enzymatic reference 326 
method with hexokinase (Melbourne Pathology, Melbourne, Australia). Plasma insulin, 327 
leptin, adiponectin, plasminogen activator inhibitor type 1 (PAI-1), tumour necrosis factor α 328 
(TNF-α) and interleukin-6 (IL-6) were measured on 96-well plates utilizing commercially 329 
available and customised Milliplex Human magnetic bead panels (Millipore, Massachusetts, 330 
USA) following the kit-specific protocols provided by Millipore. Analytes were quantified in 331 
duplicate using the Magpix system utilising xPONENT 4.2 software. Concentrations of all 332 
analytes were determined on the basis of the fit of a standard curve for mean fluorescence 333 
intensity versus pg/mL. Two quality controls with designated ranges were run with each 334 
assay to ensure validity of data generated. For the quantification of active ghrelin, whole 335 
blood samples (1 ml) were transferred to eppendorf tubes containing 1 mg 4-(2-aminoethyl)-336 
benzene sulfonylfluoride (AEBSF; Sigma Aldrich, Castle Hill, Australia). Samples were then 337 
incubated at room temperature for 30 mins to clot and then centrifuged at 3,000g for 15 min 338 
at 4°C. Plasma samples were then acidified with 4 µL 1N Hydrochloric acid and then stored 339 
at -80°C. A sandwich ELISA (Millipore, Massachusetts, USA) incorporating 340 
spectrophotometric absorbance was used to measure active ghrelin levels. C-reactive protein 341 
levels were quantified via enzyme immunoassay (IBL-International, Männedorf, 342 
Switzerland). Plasma FFA concentrations were determined by an enzymatic colorimetric 343 
method (Wako Diagnostics, Tokyo, Japan). 344 
 345 
Immunoblotting Approximately 30 mg of muscle was homogenized in ice-cold buffer as 346 
previously described (27). Lysates were centrifuged at 12,000 g for 30 min at 4 °C and the 347 
supernatant was transferred to a sterile microcentrifuge tube and aliquoted to measure protein 348 
concentration using a bicinchoninic acid protein assay (Pierce, Rockford, IL, USA). Lysate 349 
was then re-suspended in 4X Laemmli sample buffer with 40 µg of protein loaded onto 4–350 
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20% Mini-PROTEAN TGX Stain-Free™ Gels (BioRad Laboratories, Gladesville, Australia). 351 
Post electrophoresis, gels were activated on a Chemidoc according to the manufacturer’s 352 
instructions (BioRad Laboratories, Gladesville, Australia) and then transferred to 353 
polyvinylidine fluoride (PVDF) membranes. After transfer, a stain-free image of the PVDF 354 
membranes for total protein normalization was obtained before membranes were rinsed 355 
briefly in distilled water and blocked with 5% non-fat milk, washed with 10 mM of Tris–356 
HCl, 100 mM of NaCl, and 0.02% Tween 20, and incubated with primary antibody (1:1000) 357 
overnight at 4 °C. Membranes were then incubated with secondary antibody (1:2000), and 358 
proteins were detected via enhanced chemiluminescence (Thermo Fisher, Scoresby, 359 
Australia) and quantified by densitometry (ChemiDoc™ XRS+ System; BioRad 360 
Laboratories, California, USA). Exercise and Non-Exercise pre- and post-samples were run 361 
on the same gel. Primary antibodies used were phospho- 4E-BP1Thr37/46 (#2855), 362 
mTORSer2448 (#2971), p70S6KThr389 (#9205), AMPKαThr172 (#2531) and total 4E-BP1 363 
(#9644), mTOR (#2972), p70S6K (#9202) and AMPKα (#2532). All antibodies were 364 
purchased from Cell Signaling Technology (Danvers, USA). Volume density of each target 365 
phospho protein band was normalized to its respective total protein content, while the total 366 
protein band was normalised to the total protein loaded into each lane using stain-free 367 
technology (28), with data expressed in arbitrary units. 368 
 369 
RNA Extraction, Quantification, Reverse Transcription and Real-Time PCR Skeletal muscle 370 
tissue RNA extraction was performed using a TRIzol-based kit according to the 371 
manufacturer’s protocol (Invitrogen, Melbourne, Australia). In brief, approximately 20 mg of 372 
frozen skeletal muscle was homogenized in TRIzol with chloroform added to form an 373 
aqueous RNA phase. This RNA phase was then precipitated by mixing with isopropanol 374 
alcohol and the resulting pellet was washed and re-suspended in 50 µL of RNase-free water. 375 
Extracted RNA was quantified using a NanoDrop 2000 Spectrophotometer (Thermo 376 
Scientific, Scoresby, VIC, Australia). Reverse transcription and real-time Polymerase Chain 377 
Reaction (RT-PCR) was performed as previously described (29). In brief, first-strand 378 
complementary DNA (cDNA) synthesis was performed using commercially available 379 
TaqMan Reverse Transcription Reagents (Invitrogen, Melbourne, Australia). Quantification 380 
of mRNA in duplicate was performed using a CFX96 Touch™ Real-Time PCR Detection 381 
System (Bio Rad, California, USA). TaqMan-FAM-labelled primer/probes for Atrogin-1 382 
(Hs01041408_m1), Myostatin (Hs00976237_m1), Muscle Ring Finger-1 (MuRF-1; 383 
Hs00822397_m1), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 384 
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(PGC-1α; Hs01016719_m1), Pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4; 385 
Hs01037712_m1), IL-6 (Hs00174131_m1), G protein-coupled receptor 56 (GPR56; 386 
Hs00938474_m1), and Fatty Acid Translocase Cluster of Differentiation 36 (FAT/CD36; 387 
Hs00354519_m1) were used in a final reaction volume of 20 μl. 18S ribosomal RNA (Cat. 388 
No. 4333760T) was used to normalize threshold cycle (CT) values and was stably expressed 389 
between post-exercise and between the different exercise conditions (data not shown). The 390 
relative amounts of mRNAs were calculated using the relative quantification (∆∆CT) method 391 
(30). 392 
 393 
Statistical analysis  394 
For all DPP analyses, baseline differences between the independent groups were investigated 395 
by one-way ANOVA of Pre samples taken prior to deuterium oxide administration using R 396 
software for statistical computing. Within subject differences that occurred among Pre, Day 397 
3, Day 6 and Day 9 samples were investigated using repeated measures ANOVA and 398 
separate tests were performed to investigate differences in either REX or HFLC groups. To 399 
control the false discovery rate (FDR), P-value distributions were used to calculate q-values 400 
and a criterion FDR of <1% was set. This statistical approach considers the biological 401 
variation across each protein and is, therefore, more sophisticated than arbitrarily 402 
implementing a threshold based on fold-change. Statistics for remaining analyses were 403 
performed using SigmaPlot (Version 12, Systat Software). Normal distribution and equal 404 
variance of the data were tested using Shapiro-Wilk and F tests, respectively. Two-way 405 
ANOVA followed by Student Newman Kuel’s post-hoc tests were performed to determine 406 
differences between REX and HFLC groups, and time (Pre, D3, D6, and Post). All data in 407 
text and figures are presented as mean ± SEM with P values <0.05 indicating statistical 408 
significance. 409 
 410 
Results 411 
Effects of High Fat Low Carbohydrate Diet and Resistance Exercise on Glucose Metabolism, 412 
Free Fatty Acids and Plasma Markers of Inflammation and Appetite Control 413 
Consumption of HFLC diet did not result in differences in plasma insulin or glucose in 414 
response to an OGTT in either group (Figure 2A, B) although REX tended to lower glucose 415 
area under the curve between D0 and D9 (Figure 2C, P = 0.150). The HFLC diet increased 416 
fasting plasma non-esterified free fatty acids (FFA) in both groups, measured on the four 417 
mornings muscle biopsies were taken (P<0.05, Figure 3A).   418 
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There were main effects for time for IL-6 and TNF-α (P<0.05; Figure 3). IL-6 increased 419 
~390% at Day 6 compared to Post in participants that performed REX (P<0.05). Similarly, 420 
TNF-α was highest at Day 6 in both groups and was ~205% and ~140% above Pre in REX 421 
and HFLC groups, respectively (P<0.05, Figure 3). There were non-significant increases in 422 
C-reactive protein, Pre-to-Post intervention (Figure 3). We also investigated the effects of our 423 
HFLC diet on the appetite and energy balance regulating hormones ghrelin and leptin. We 424 
observed non-significant decreases in these markers following our dietary intervention. There 425 
were also no changes in the concentrations of adiponectin or plasminogen activator inhibitor 426 
type 1 (PAI-1), circulating factors previously associated with insulin resistance (31, 32), 427 
between the REX and HFLC groups or throughout the dietary intervention (Figure 3). 428 
Dynamic proteome profiling of human muscle proteins 429 
On average, the molar per-cent enrichment (MPE) of D2O in body water increased at a rate of 430 
0.135 ± 0.005 % per day and reached a peak of 2.14 ± 0.08 % on day 9. Label-free proteome 431 
profiling was conducted on proteins that had one or more unique peptides that were measured 432 
in all 16 participants at each of the four experiment time points. In the myofibrillar fraction, 433 
38 proteins were analysed and included each of the major components of the muscle thick 434 
and thin myo-filaments. Analysis of the sarcoplasmic fraction encompassed 88 proteins with 435 
the majority of these having biological functions associated with the generation of precursor 436 
metabolites and belong to KEGG pathways including glycolysis/glycogenolysis, the 437 
tricarboxylic acid cycle and pyruvate metabolism.  438 
 439 
The rate constant (k) of synthesis of each protein was calculated by fitting mass isotopomer 440 
data to a non-linear model (Figure 4) described previously in (19). After filtering to remove 441 
peptides with relatively poor fitting data (R2 <0.99), 31 of the 38 myofibrillar proteins and 60 442 
of the 88 sarcoplasmic proteins were retained (Supplementary tables report raw (S1 and S2) 443 
and summary (S3) mass spectrometry data). Figure 5 displays the rank order of synthesis 444 
rates for the 91 proteins investigated in the muscle of both groups of participants. Pyruvate 445 
dehydrogenase E1 component subunit beta (ODPB) had the lowest synthesis rate (0.08 ± 0.08 446 
% per day), whereas carbonic anhydrase 3 (CAH3) exhibited the greatest synthesis rate (23.8 447 
± 5.8 % per day). The median and inter-quartile range (IQR) synthesis rate was 2.29 % per 448 
day (IQR 1.4 - 3.2 %/d) in the myofibrillar fraction and 3.1 % per day (IQR 0.9 – 3.9 %/d) in 449 
sarcoplasmic fraction. There was no difference (P=0.317) in the rate of synthesis of proteins 450 
analysed in the myofibrillar versus sarcoplasmic fractions. There was no association (ρ -0.08, 451 
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P=0.3925) between the rate of synthesis of a protein and its relative abundance in either the 452 
myofibrillar or sarcoplasmic fractions. 453 
 454 
The effect of High Fat Low Carbohydrate Diet and Resistance Exercise on muscle protein 455 
abundances 456 
Prior to the diet and exercise intervention there were no differences in muscle protein 457 
abundance between groups. The relative proportions of myosin heavy chain (MyHC) 458 
isoforms, which are commonly used to phenotype skeletal muscle, were 60 % MyHC 1, 31 % 459 
MyHC 2a and 9 % MyHC 2x in REX participants and were similar to participants in the 460 
HFLC group (63 % MyHC 1, 28 % MyHC 2a and 9 % MyHC 2x). Within-subject analysis of 461 
changes in protein abundance over the duration of the study period did not reveal any 462 
significant changes in protein abundance in the muscle of HFLC participants. In contrast, 17 463 
proteins exhibited significant differences in abundance between baseline (D0) and D9 in the 464 
muscle of the REX group. With the exception of troponin C, the changes in protein 465 
abundance were reported from analysis of the sarcoplasmic fraction. Figure 6 presents a 466 
volcano plot of protein abundance data from REX participants and displays the fold change in 467 
protein abundance between D0 and D9 of the intervention. In total, 11 proteins increased and 468 
6 decreased in abundance in response to the resistance exercise training and diet intervention. 469 
 470 
The effect of High Fat Low Carbohydrate Diet and Resistance Exercise on the synthesis of 471 
muscle proteins 472 
The average rate of synthesis of myofibrillar proteins was 1.58 ± 0.08 % per day in 473 
participants that performed REX. This synthesis response was significantly greater than the 474 
1.09 ± 0.06 % per day in the muscle from HFLC only participants (P< 0.001, Figure 7). This 475 
effect of REX was not detected in the sarcoplasmic fraction where the average synthesis rate 476 
was similar between groups (REX = 2.15 ± 0.15 % /d, HFLC = 2.05 ± 0.17 % /d). When 477 
considered on a protein-by-proteins basis, 13 proteins (7 myofibrillar and 7 sarcoplasmic) had 478 
significantly greater rates of synthesis in the REX group (P<0.05, Figure 8).  479 
 480 
Protein responses to High Fat Low Carbohydrate Diet and Resistance Exercise 481 
Figure 9 summarises data from the REX group comparing within subject changes in protein 482 
abundance with between group analysis of differences in protein synthesis rate against the 483 
HFLC group and illustrates the variety of different responses of muscle proteins to resistance 484 
exercise. Proteins positioned in the upper left quadrant were less abundant after REX but 485 
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exhibited a greater rate of synthesis in exercised versus non-exercised muscle. Conversely, 486 
the abundance of proteins in the lower right quadrant increased in response to resistance 487 
exercise but their rate of synthesis was less than that measured in non-exercised muscle that 488 
did not exhibit any change in protein abundance. 489 
 490 
Table 2 categorises exercise responsive proteins (categories i-vi) according to the pattern of 491 
the response observed in the REX group. The most common response to exercise was an 492 
increase in turnover rate without any significant change in abundance, and proteins that 493 
exhibited this response were mostly of myofibrillar origin (10 proteins). The second and third 494 
most numerous groups of proteins exhibited significant changes in abundance that were 495 
primarily attributable to differences in breakdown rate (i.e. protein abundance changed but 496 
there was no significant difference in synthesis rate). Proteins that increased in abundance 497 
(Table 2 category ii) included cytoskeletal binding proteins (ACTS, FLNC and PROF1) and 498 
cytoplasmic or membrane-bound vesicle proteins (ALBU, PRDX6, TRFE) that have anti-499 
oxidant (PRDX6, ALBU) functions, whereas glycolytic enzymes were common amongst 500 
proteins that decreased in abundance (Table 2 category iii).  Two other glycolytic enzymes 501 
exhibited unique responses including beta enolase, which was significantly less abundant 502 
after exercise training despite its rate of synthesis being significantly greater in exercised 503 
versus non-exercise trained muscle. Conversely, aldolase A did not change in abundance in 504 
REX muscle but its rate of synthesis was significantly less than reported in the HFLC group.  505 
 506 
Modulation in gene and protein markers of translation initiation mitochondrial biogenesis, 507 
and muscle proteolysis following HFLC diet 508 
The expression of the ubiquitin E3 ligases Muscle-specific RING Finger protein1 (MuRF1) 509 
and Muscle Atrophy F-box (MAFbx/atrogin-1) decreased ~160% post-intervention in the 510 
REX group only, resulting in a ~115-230% differential expression between groups post-511 
intervention (P<0.05; Figure 9). Myostatin decreased by 140% post-intervention in the REX 512 
cohort and compared to the HFLC (~200%, P<0.05; Figure 10). REX also attenuated PPARδ 513 
mRNA expression compared to the non-exercise group by ~40% post-intervention (Figure 9), 514 
while the transcriptional co-activator PGC-1α decreased by ~130% in both groups post-515 
intervention (Figure 9). There were no changes in FAT/CD36, GPR56, PDK4 or IL-6 mRNA 516 
expression (Figure 9). Western blot analyses on key mTOR related signalling substrates that 517 
regulate translation initiation processes revealed a ~50% increase in total mTOR abundance 518 
in REX compared to HFLC post-intervention (P<0.05; Figure 11). The phosphorylation state 519 
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or total amount of p70S6K, 4E-BP1 and AMPK were unaltered between groups or post-520 
intervention (Figure 10). 521 
 522 
Discussion 523 
In an effort to find therapeutic strategies to combat conditions such as sarcopenia, the 524 
anabolic response of muscle to resistance exercise and nutrition has been a longstanding 525 
focus of many clinical investigations. Previous application of peptide mass spectrometry and 526 
deuterium oxide has enabled measurement of synthesis rates for numerous proteins in human 527 
muscle (20). For the first time we report fully integrated proteomic profiling in association 528 
with deuterium labelling to simultaneously measure the rate of synthesis, net abundance and 529 
rate of breakdown of human muscle proteins in response to a diet-exercise intervention. 530 
Muscle anabolism induced by resistance exercise is typically regarded as being driven by 531 
synthetic processes, but using dynamic proteome profiling (DPP), we provide novel data to 532 
show that exercise-induced changes in muscle protein occur through several different patterns 533 
of response involving modulation of both synthetic and degradative processes. Such 534 
multiplicity in the adaptive response of the proteome (Figure 8) has not previously been 535 
captured and is a unique aspect of the current investigation. 536 
 537 
New techniques have recently been developed incorporating D2O labelling with proteomic 538 
analyses including peptide mass spectrometry, which measure the rate constant (k) for 539 
synthesis on a protein-by-protein basis in the muscle of animals (33-36) and humans (20). 540 
Collectively, these works and our current data (Figure 5) demonstrate that there is a broad 541 
range of different synthesis rates of muscle proteins. These results highlight the advantages of 542 
interrogation of protein-specific synthetic responses (as opposed to the average gross 543 
synthesis of mixed proteins from whole muscle or muscle fractions) to discover novel 544 
therapeutic targets and provide mechanistic insight into protein metabolism. Moreover, 545 
results from these studies that show that protein synthesis rates differ, providing evidence for 546 
the selective breakdown of proteins at different rates in order to maintain the same relative 547 
abundance of proteins in tissue (i.e. maintenance of muscle mass). Chronic resistance training 548 
(i.e., 16 weeks) is associated with selective changes in protein abundance, such as a shift 549 
toward a greater proportion of the type IIa myosin heavy chain isoform (37). Resistance 550 
exercise increases the synthesis of mixed myosin heavy chains (38) but our data (Figures 4 551 
and 8) is the first to shown this effect is confined to the fast-twitch IIa (MYH2). This ability 552 
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to measure the synthesis of key proteins such as MYH2 will be important to the future study 553 
of the effects of resistance training in older adults with muscle wasting conditions. 554 
In the current study, we reasoned that, when investigated at a protein-specific level, the 555 
average rate of breakdown can be estimated from the difference between its measured change 556 
in relative abundance and its rate of synthesis over that time period. That is, because the 557 
synthesis, abundance and degradation of the protein are intimately connected then any change 558 
in abundance that is not explained by the measured rate of synthesis during that period may 559 
be a function of the rate of breakdown of that protein. Eleven proteins (Table 2) exhibited 560 
negative values for the calculated rate of breakdown (i.e. the measured increase in protein 561 
abundance was greater than the accumulative increase predicted from the measured synthesis 562 
rate). While this may be attributable to technical errors associated with the measurement of 563 
protein abundance and/or synthesis rate, it may also reflect secretion and delivery to muscle 564 
of pre-existing protein, which would have the effect of increasing protein abundance to a 565 
greater extent than predicted by synthesis alone. ALBU and TRFE each exhibited ‘negative’ 566 
breakdown rates and, while abundant in muscle (15), these proteins are predominantly 567 
expressed in the liver, secreted into the plasma and become resident in the muscle interstitial 568 
space, which would have the effect of concentrating their abundance in a process distinct 569 
from the synthesis process capture by deuterium oxide labelling. Similarly, the increases in 570 
ACTS and TNNC2 could be explained by the translocation of soluble, pre-myofibril 571 
complexes from the sarcoplasmic fraction and incorporation into mature myofibrils through 572 
the process of myofibril assembly (39). 573 
The potential involvement of myofibril assembly brings context to other findings from our 574 
DPP data. Pre-myofibrils contain thin filament proteins (e.g. actin, troponin and 575 
tropomyosin), costameric proteins (e.g. desmin and filamin) and z-band/z-body proteins (e.g. 576 
alpha-actinin) that were responsive to resistance exercise (Table 2). Desmin has largely been 577 
associated with lateral force transmission from contracting sarcomeres to the muscle exterior 578 
(40) and is already known to increase in human muscle after resistance training (41). Our 579 
findings raise the question whether part of this response is associated with myofibril 580 
assembly, often an understudied area in the context of exercise adaptation. We also report 581 
increases in the abundance of ankyrin repeat domain protein 2 (ANKR2) and 27 kDa heat 582 
shock protein (HSPB1) in the sarcoplasmic fraction, and a greater turnover of alpha B-583 
crystallin (CRYAB) specifically in the myofibrillar fraction of exercised muscle. These 584 
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findings are consistent with earlier work (42, 43) and the responses observed for these 585 
proteins may be necessary to stabilise cytoskeleton and myofibril structures or prevent 586 
protein denaturation (44). Similarly Alpha B-crystallin translocates to and stabilises 587 
myofibrils in response to contractile stress (45) and this event is evidenced in our DPP data 588 
by the calculated ‘negative’ breakdown rate for CRYAB. 589 
 590 
The greater (1.58 %/d) synthesis of myofibrillar proteins in exercised muscle (Figure 6) 591 
matches the 1.6 %/d rate reported by Brook et al (13) during the first three weeks of a similar 592 
resistance training stimulus. A potential limitation of our experimental design is that we did 593 
not include a healthy ‘control’ diet so we cannot compare the effect of a HFLC diet on 594 
muscle protein synthesis to other dietary interventions. Nevertheless, the average synthesis 595 
rate of myofibrillar proteins (1.09 %/d) in HFLC participants is less than reported in 596 
untrained muscle (1.35 %/d) by Brook et al (13). Of note was that the HFLC diet alone did 597 
not alter the abundance of muscle proteins suggesting there was little effect on muscle protein 598 
synthesis response. When combined with resistance exercise there was a decrease in the 599 
abundance of four glycolytic enzymes (Table 2, categories iii and v) and a lower synthesis 600 
rate for aldolase A. This contrasts with the increase in glycolytic metabolism that has 601 
previously been associated with resistance training (46, 47) although we also report two 602 
glycolytic enzymes (Table 2, category i) exhibited greater turnover in exercised muscle. This 603 
response may be associated with maintaining enzyme pool efficiency (19, 48) and a similar 604 
response has been reported previously in mouse heart during isoprenaline-induced cardio-605 
toxicity (37).  606 
 607 
MEK-ERK signalling has previously been associated with anabolic responses to resistance 608 
exercise (49, 50) and may have contributed to the differences between HFLC and REX 609 
groups. Degradation of phosphatidylethanolamine-binding protein 1 (PEBP1; also known as 610 
RAF kinase inhibitor protein RKIP) was greater in exercised muscle and resulted in 611 
significantly less RKIP abundance, which may enhance signalling through the MEK-ERK 612 
pathway (51). RKIP is also a component in the diacylglycerol (DAG)-sensitive PKC pathway 613 
that increases IL-6 expression in response to saturated fatty acids (52) and we observed 614 
greater IL-6 mRNA expression and plasma concentration of IL-6 in resistance-exercised 615 
individuals. New data from the model organism C. Elegans also implicates RKIP in protein 616 
breakdown (53) and RKIP/PEBP1 was reported to be an inhibitor of starvation-induced 617 
autophagy in mammalian cells (54). Here, mRNA expression of ubiquitin E3 ligases 618 
 20 
(Atrogin-1 and MuRF-1) was lower in exercised muscle, which may indicate the ubiquitin-619 
proteasomal system is not the primary mechanism for the observed greater breakdown of 620 
selected proteins (Table 2, categories i, ii and iii). Other processes that could be responsible 621 
for the breakdown of these proteins include chaperone-assisted selective autophagy (CASA). 622 
Filamin-C (FLNC), which is an actin-binding protein that may be involved in mechano-623 
transduction and intracellular signalling (55) and Ulbricht and colleagues recently 624 
demonstrated increased FLNC mRNA and protein levels after maximal eccentric exercise in 625 
human skeletal muscle (56). As filamin-C is thought to be damaged during eccentric muscle 626 
contraction it may require removal by autophagy in exercised muscle (57). CASA is 627 
implicated in these responses and inhibition of CASA may also be responsible, in part, for the 628 
increased abundance (Table 2 category ii) detected with DPP and RKIP. 629 
 630 
In conclusion, the response of human muscle protein turnover to resistance exercise training 631 
differs on a protein-by-protein basis (Table 2). Of the proteins that were altered by the 632 
exercise stimulus, the most common response was an increase in turnover (i.e. the increase in 633 
synthesis rate was matched by an increase in the rate of breakdown resulting in no 634 
measurable change in protein abundance). We report that changes in protein abundance in 635 
response to resistance exercise are underpinned by regulation of either synthetic or 636 
degradative processes, or a combination of both. While such concepts are not new, it has been 637 
challenging to collect empirical data to support this paradigm in human tissue. We show DPP 638 
can provide data on the synthesis, abundance and breakdown of individual proteins. As such, 639 
use of DPP in future studies has the potential to significantly advance knowledge of exercise-640 
induced adaptations as well as patho-biochemical processes associated with chronic human 641 
muscle-wasting diseases and muscle loss with ageing. For example, the application of DPP in 642 
chronic interventions could uncover how the response of enhanced turnover reported here is 643 
converted into protein accretion and myofibre hypertrophy, and whether increases in 644 
synthesis continue are sustained (and for how long) or if the rate of breakdown subsides with 645 
longer period of resistance exercise training.  646 
 647 
 648 
Conflict of Interest Statement 649 
The authors declare that the research was conducted in the absence of any commercial or 650 
financial relationships that could be construed as a potential conflict of interest. 651 
 21 
Author contributions  652 
DMC, JGB and JAH designed the study, DMC and WJS conducted the experiment, DMC, 653 
JGB and MAP performed the biochemical assays and data analyses, DMC, JGB and JAH 654 
wrote the manuscript and all authors approved the manuscript prior to submission. 655 
 656 
Acknowledgements  657 
We thank the study participants for their efforts and dedication. This study was funded by an 658 
Australian Catholic University Collaborative Research Network Grant to J. A. Hawley 659 
(2013000443). 660 
 661 
 662 
 663 
 664 
 665 
 666 
 667 
 668 
 669 
 670 
 671 
 672 
 673 
 674 
 675 
 676 
 677 
 678 
 679 
 680 
 681 
 682 
  683 
 22 
Figure legends  684 
Table 1. 685 
Baseline Characteristics of the participants in the REX and HFLC groups. 686 
 687 
Table 2. 688 
Pattern of muscle proteome responses of individual proteins observed in the REX group 689 
between and D0 and D9. For the purpose of comparison/ calculation, changes in abundance 690 
have been converted to rate of change in abundance. 691 
 692 
Figure 1. D2O-labeling protocol and peptide enrichment. (A) After 3 days of dietary control 693 
participants consumed a high-fat low-carbohydrate (HFLC) diet (8% Carbohydrate, 77% Fat, 694 
15% Protein) and undertook three sessions of resistance exercise (REX), or consumed the 695 
HFLC with no exercise (HFLC). Participants ingested deuterium oxide (200 ml/ d) during a 696 
9-day intervention period, venous blood samples were collected daily and samples of vastus 697 
lateralis were collected prior to (i.e. morning of day 0) and during (days 3, 6 and 9) the 698 
intervention. Blood and muscle samples were analysed by mass spectrometry to determine 699 
precursor enrichment and the rate of incorporation of deuterium in to newly synthesised 700 
protein, respectively.  701 
 702 
Figure 2. The effects of high-fat low-carbohydrate diet and resistance exercise on blood 703 
glucose homeostasis. Differences in plasma insulin (A), glucose (B) and glucose area under 704 
the curve (C) in participants who performed resistance exercise (REX) or consumed a high 705 
fat low-carbohydrate (HFLC) diet only. Data are presented as mean ± SEM; n = 8 in REX/ n 706 
= 7 in HFLC, a = P < 0.05 to ‘Rest’ within group, d = P < 0.05 to ’90 min’ within group, e = 707 
P < 0.05 to ‘120 min’ within group; 2-way ANOVA.  708 
 709 
Figure 3. Metabolite and hormone responses to high-fat low-carbohydrate diet and resistance 710 
exercise. Differences in plasma concentrations of Free fatty acids (A), Adiponectin (B), PAI-711 
1 (C), IL-6 (D), TNF-α, (E), Leptin (F) and C-reactive protein (G) and (H) Ghrelin.  Data 712 
represent resistance trained (REX) participants who performed exercise and consumed a high 713 
fat low carbohydrate diet and control (HFLC) participants who consumed the high fat low 714 
carbohydrate diet only. Data are presented as mean ± SEM; n = 8 in REX/ n = 7 in HFLC, * 715 
= P < 0.05 between REX and HFLC, # = P < 0.05 interaction for time; 2-way ANOVA.  716 
 717 
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Figure 4. (A) Example mass spectra of peptide LAQESIMDIENEK ([M+2H] 2+ = 760.3837 718 
m/z) from the type IIa isoform (MYH2) of myosin heavy chain. The relative abundances of 719 
m0 (monoisotopic), m1, m2, m3 and m4 mass isotopomers at D0, D3, D6 and D9 is 720 
presented. The incorporation of deuterium in to newly synthesised protein is evident in the 721 
proportional increase in the ‘heavy’ isotopomers (m1, m2, m3 and m4) and relative decrease 722 
in the fractional abundance of the monoisotopic peak (i.e. m0/Σmi). The mean ± SD and 723 
coefficient of variation (%CV) is reported for exercise trained participants (n = 8).  (B) The 724 
rate constant of synthesis was calculated by fitting mass isotopomer data (m0/Σmi) to a non-725 
linear model of the rise in precursor enrichment and incorporation of deuterium in to the 726 
product peptide, taking in to account the amino acid composition of the peptide. (C) The 727 
fractional synthesis rate (k) of MYH2 in exercised muscle (0.0187 ± 0.0032) was 728 
significantly (P=0.016) greater than control (0.0096 ± 0.0017) based on mass isotopomer 729 
distribution analysis of 5 peptides investigated in n=8 participants per group. 730 
 731 
 732 
Figure 5. Rank order of protein synthesis rates in human skeletal muscle.  (A)  The mean rate 733 
constant (k) for the synthesis of each protein ranked from least to greatest from D0 to D9.  734 
Data represent proteins analysed in the myofibrillar pellet (blue) and sarcoplasmic/ soluble 735 
muscle fraction (orange) of both diet control (HFLC) and resistance exercised (REX) 736 
participants.  Labels indicate the UniProt knowledgebase identifiers for a sub-selection of 737 
proteins.  The size (radius) of each data point represents the mean normalised abundance of 738 
each protein in baseline (day 0) samples. (B) Boxplots presenting the average (median and 739 
interquartile range) rate constant of synthesis of proteins analysed in the myofibrillar pellet 740 
and soluble muscle fraction from D0 to D9. Independent two-tailed t-test found no significant 741 
(P=0.317) difference in the average rate of synthesis of proteins in myofibrillar (n=31) vs 742 
sarcoplasmic (n=60) proteins.  743 
 744 
Figure 6. The effects of resistance exercise on muscle protein abundance. Volcano plot 745 
presenting pre- (day 0) versus post-intervention (day 9) changes (Fold change (Log2)) in 746 
resistance trained (REX) participants. There were no significant differences in protein 747 
abundance in the muscle of control participants who consumed the high-fat low-carbohydrate 748 
(HFLC) diet only. P values were calculated from log-transformed data using within-subject 749 
(repeated measures) one-way analysis of variance. Proteins that exhibited a statistically 750 
significant (p<0.05) change in abundances are coloured red if the calculated false discovery 751 
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rate (FDR) is < 5 % or blue if FDR is > 5 % and less than 10 %. Labels represent the Uniport 752 
Knowledgebase identifier of each of the statistically significant proteins.  753 
 754 
Figure 7. The effect of three bouts of resistance exercise on the average synthesis rate of 755 
human muscle proteins. Data are presented using violin plots overlaid with box plots that 756 
represent the average (median and interquartile range) rate of synthesis of mixed myofibrillar 757 
or soluble muscle proteins. Exercise participants performed resistance training (REX) and 758 
consumed a high-fat low-carbohydrate diet, whereas control (HFLC) participants consumed 759 
the high-fat low-carbohydrate diet only (n = 8/group). Two-tailed independent t-tests found 760 
the synthesis rate of mixed myofibrillar proteins was significantly (P<0.001) greater in REX 761 
compared to HFLC. There was no significant (P=0.531) difference in the rate of synthesis of 762 
sarcoplasmic proteins between groups.  763 
 764 
Figure 8. The effects of resistance exercise on the synthesis rate of muscle proteins in REX 765 
participants only. Volcano plot presenting differences (Fold-difference (Log2)) in the rate of 766 
synthesis of proteins between participants who performed resistance exercise (REX) and or 767 
those who consumed a high-fat low-carbohydrate (HFLC) diet only. P values were calculated 768 
from log-transformed data (n=8/ group) using between-subject one-way analysis of variance.  769 
Proteins that exhibited a statistically significant (p<0.05) change in abundances are coloured 770 
red if the calculated false discovery rate (FDR) is < 5 % or blue if FDR is >5 % and less than 771 
10 %. Labels represent the Uniport Knowledgebase identifier of each of the statistically 772 
significant proteins.  773 
 774 
Figure 9. Dynamic proteome responses to resistance exercise in the myofibrillar (A) and 775 
sarcoplasmic (B) fractions. Summary data presented are from resistance exercised (REX) 776 
participants only. There were no changes in protein abundance in HFLC control participants 777 
who consumed a high-fat low-carbohydrate diet only. Upper left quadrant = decrease in 778 
abundance over the duration of the experiment but greater rate of synthesis compared to 779 
HFLC participants. Upper right quadrant = proteins that increased in abundance in the muscle 780 
of REX participants and protein synthesis rate was also greater in REX compared to HFLC.  781 
Lower left quadrant = Decrease in abundance after REX while synthesis rate is also less than 782 
HFLC participants.  Lower right quadrant = increase in abundance after REX despite the 783 
synthesis rate being less than HFLC participants. 784 
 785 
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Figure 10. Differences in mRNA expression of (A) Atrogin-1, (B) MuRF-1, (C) Myostatin, 786 
(D) FAT/CD36, (E) GPR56, (F) PDK4, (G) PGC1-α, (H) PPAR-δ and (I) IL-6. Data 787 
represent REX participants who performed resistance exercise and consumed a high fat low 788 
carbohydrate diet and HFLC participants who consumed the high fat low carbohydrate diet 789 
only (mean ± SEM; n = 6 in REX/ n = 5 in HFLC, * = P < 0.05 between REX and HFLC, a = 790 
P < 0.05 to ‘Rest’ within group; 2-way ANOVA). 791 
 792 
Figure 11. Differences in phosphorylation status of (A) 4E-BP1Thr37/46, (C) AMP 793 
KinaseThr172, (E) mTORSer2448, (G) p70S6KThr389, and total abundance of (B) 4E-BP1, 794 
(D) AMPKα, (F) mTOR and (H) p70S6K. Data represent REX participants who performed 795 
resistance exercise and consumed a high fat low carbohydrate diet and HFLC participants 796 
who consumed the high fat low carbohydrate diet only (mean ± SEM; n = 5 in REX/ n = 4 in 797 
HFLC, * = P < 0.05 between REX and HFLC; 2-way ANOVA). 798 
 799 
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Table 1.  
Baseline Characteristics of the participants 
 REX 
(n = 8) 
HFLC 
(n = 8) 
Age (y) 36.9 ± 1.9 36.9 ± 2.1 
Body Mass (kg) 88.8 ± 4.2 85.5 ± 3.4 
BMI (kg m-2) 26.9 ± 1.0 26.4 ± 1.1 
Fat Free Mass (kg) 60.4 ± 2.0 57.8 ± 2.6 
Fat Mass (kg) 24.9 ± 2.9 24.5 ± 2.1 
VO2peak (ml/kg/min) 39.7 ± 1.9 36.5 ± 2.2 
VO2peak (L/min) 3.5 ± 0.1 3.1 ± 0.2 
Leg Extension 1-RM (kg) 79.8 ± 5.0 76.5 ± 6.6 
Leg Press 1-RM (kg) 221.0 ± 6.0 217.6 ± 16.1 
 819 
Values are given as mean ± SEM. 820 
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Table 2  821 
Protein identifier 
(UniProt ID) 
Protein name Abundance 
change 
(%/d) 
Fractional 
synthesis rate 
(%/d) 
Fractional 
breakdown rate 
(%/d) 
(i) Increased turnover, no change in abundance 
ACON Aconitase -3.34 3.46 6.8 
ACTN2 Alpha-actinin 2 +1.83 4.54 2.71 
CRYAB Alpha B-crystallin +3.89 4.38 0.49 
DESM Desmin -1.55 4.25 5.8 
LDHA Lactate dehydrogenase -3.34 9.63 12.97 
MLRS Myosin regulatory light chain 2 +2.82 1.25 -1.57 
MYH2 Myosin heavy chain 2 -0.11 1.88 1.99 
MYL1 Myosin light chain 1/3 +1.55 2.53 0.98 
PGM1 Phosphoglucomutase 1 -1.45 1.09 2.54 
TPM2 Tropomyosin beta 2.65 0.93 -1.72 
     
(ii) Significant increase in abundance with no difference in synthesis rate 
ACTS Actin, alpha skeletal muscle +3.17 1.41 -1.76 
ALBU Serum albumin +8.9 3.21 -5.69 
ENOA Alpha enolase +2.2 3.62 1.42 
FLNC Filamin C +8.13 12.45 4.32 
 28 
IGHG4 Ig gamma-4 chain C region +14.7 8.77 -5.93 
PRDX6 Peroxiredoxin-6 +2.12 6.07 3.95 
PROF1 Profilin-1 +3.73 1.22 -2.51 
TNNC2 Troponin C +5.29 1.52 -3.77 
TRFE Serotransferrin +10.56 7.25 -3.31 
     
(iii) Significant decrease in abundance but no significant difference in synthesis 
AT2A1 Sarcoplasmic/endoplasmic reticulum Ca2+ ATPase -1.45 6.90 8.35 
G3P Glyceraldehyde-3 phosphate dehydrogenase -2.74 0.24 2.98 
PEBP1 Phosphatidylethanolamine-binding protein 1 -2.21 0.42 2.63 
PGAM2 Phosphoglycerate mutase 2 -3.56 5.35 8.91 
TPIS Triosephosphate isomerase -2.12 0.72 2.84 
     
(iv) Significant increase in abundance and significantly greater synthesis rate 
 
HSPB1 Heat shock protein beta-1 +4.72 6.22 1.5 
ANKR2 Ankyrin repeat domain-containing protein-2 +4.43 6.17 1.74 
     
(v) Significant decrease in abundance and significantly greater synthesis rate 
ENOB Beta-enolase -1.84 6.62 8.46 
     
 29 
(vi) No change in abundance but a significantly lesser synthesis rate 
ALDOA Fructose-bisphosphate aldolase A -1.36 4.63 5.99 
     
 822 
 823 
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